 | • レポートコード：MRC2301A064 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に7,832.48百万ドルであった世界の血液分析装置市場規模が、2022年に8,509.21百万ドルに到達し、2027年まで年平均8.89%で成長して13,060.09百万ドルまで拡大すると予測しています。本レポートは、血液分析装置の世界市場について総合的・多面的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（装置、試薬、サービス）分析、価格帯別（高価格、低価格、中価格）分析、エンドユーザー別（臨床検査室、政府リファレンスラボラトリー、病院、研究所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。本資料には、Abbott Laboratories、Beckman Coulter Inc.、Bio-Rad Laboratories, Inc.、Biosystems S.A.、Boule Diagnostics AB、Cellavision、Drucker Diagnosticsなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の血液分析装置市場規模：製品別 - 血液分析用装置の市場規模 - 血液分析用試薬の市場規模 - 血液分析サービスの市場規模 ・世界の血液分析装置市場規模：価格帯別 - 高価格血液分析装置の市場規模 - 低価格血液分析装置の市場規模 - 中価格血液分析装置の市場規模 ・世界の血液分析装置市場規模：エンドユーザー別 - 臨床検査室における市場規模 - 政府リファレンスラボラトリーにおける市場規模 - 病院における市場規模 - 研究所における市場規模 ・世界の血液分析装置市場規模：地域別 - 南北アメリカの血液分析装置市場規模 アメリカの血液分析装置市場規模 カナダの血液分析装置市場規模 ブラジルの血液分析装置市場規模 … - アジア太平洋の血液分析装置市場規模 中国の血液分析装置市場規模 インドの血液分析装置市場規模 韓国の血液分析装置市場規模 台湾の血液分析装置市場規模 … - ヨーロッパ/中東/アフリカの血液分析装置市場規模 イギリスの血液分析装置市場規模 ドイツの血液分析装置市場規模 フランスの血液分析装置市場規模 ロシアの血液分析装置市場規模 … - その他地域の血液分析装置市場規模 ・競争状況 ・企業情報 |
The Global Hematology Analyzers Market size was estimated at USD 7,832.48 million in 2021 and expected to reach USD 8,509.21 million in 2022, and is projected to grow at a CAGR 8.89% to reach USD 13,060.09 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Hematology Analyzers to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Instruments, Reagents, and Services. The Instruments is further studied across 3 Part Hematology Analyzer, 5 Part Hematology Analyzer, and Point-of-care Testing Hematology Analyzers.
Based on Price Range, the market was studied across High-end Hematology Analyzers, Low-end Hematology Analyzers, and Mid-range Hematology Analyzers.
Based on End User, the market was studied across Clinical Laboratories, Government Reference Laboratories, Hospitals, and Research Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hematology Analyzers market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hematology Analyzers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hematology Analyzers Market, including Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Biosystems S.A., Boule Diagnostics AB, Cellavision, Drucker Diagnostics, Edan Instruments, Inc., EKF Diagnostics Holdings PLC, Erba Diagnostics, Inc, F. Hoffmann-La Roche AG, Horiba Ltd, Mindray Medical International Ltd., Nihon Kohden Corporation, Ortho Clinical Diagnostics By The Carlyle Group, PixCell, PZ CORMAY S.A., Rayto Life and Analytical Sciences Co., Ltd., SAMSUNG, Shenzhen Dymind Biotechnology Co.,Ltd, Shenzhen Landwind Industry Co., Ltd, Shenzhen Prokan Electronics Inc., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hematology Analyzers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hematology Analyzers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hematology Analyzers Market?
4. What is the competitive strategic window for opportunities in the Global Hematology Analyzers Market?
5. What are the technology trends and regulatory frameworks in the Global Hematology Analyzers Market?
6. What is the market share of the leading vendors in the Global Hematology Analyzers Market?
7. What modes and strategic moves are considered suitable for entering the Global Hematology Analyzers Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of blood disorders
5.1.1.2. Recent developments in areas of genetic therapies, stem cell research, pharmacogenomics, and hemoglobinopathies
5.1.1.3. Growing consolidation of diagnostic laboratory chains
5.1.2. Restraints
5.1.2.1. Safety concerns and product recalls
5.1.3. Opportunities
5.1.3.1. Preferences rising for automated hematology instruments
5.1.3.2. Rising R&D investment and efforts in field of hematology testing
5.1.4. Challenges
5.1.4.1. Slow adoption in emerging countries
5.1.4.2. Limitation in generation of comments on red cell morphology
5.2. Cumulative Impact of COVID-19
6. Hematology Analyzers Market, by Product Type
6.1. Introduction
6.2. Instruments
6.3.1. 3 Part Hematology Analyzer
6.3.2. 5 Part Hematology Analyzer
6.3.3. Point-of-care Testing Hematology Analyzers
6.3. Reagents
6.4. Services
7. Hematology Analyzers Market, by Price Range
7.1. Introduction
7.2. High-end Hematology Analyzers
7.3. Low-end Hematology Analyzers
7.4. Mid-range Hematology Analyzers
8. Hematology Analyzers Market, by End User
8.1. Introduction
8.2. Clinical Laboratories
8.3. Government Reference Laboratories
8.4. Hospitals
8.5. Research Institutes
9. Americas Hematology Analyzers Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hematology Analyzers Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hematology Analyzers Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Beckman Coulter Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bio-Rad Laboratories, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Biosystems S.A.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Boule Diagnostics AB
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cellavision
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Drucker Diagnostics
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Edan Instruments, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. EKF Diagnostics Holdings PLC
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Erba Diagnostics, Inc
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. F. Hoffmann-La Roche AG
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Horiba Ltd
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Mindray Medical International Ltd.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Nihon Kohden Corporation
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Ortho Clinical Diagnostics By The Carlyle Group
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. PixCell
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. PZ CORMAY S.A.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Rayto Life and Analytical Sciences Co., Ltd.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. SAMSUNG
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Shenzhen Dymind Biotechnology Co.,Ltd
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Shenzhen Landwind Industry Co., Ltd
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Shenzhen Prokan Electronics Inc.
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Siemens Healthineers AG
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Sysmex Corporation
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Thermo Fisher Scientific, Inc
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing